Elizabeth Plimack

Elizabeth Plimack

Fox Chase Cancer Center - Philadelphia / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4618563
-
person_outline Elizabeth Plimack's MOST POPULAR ARTICLES
1-) Nivolumab versus everolimus in advanced renal-cell carcinomaRJ Motzer, B Escudier, DF McDermott, S George, HJ Hammers, S Srinivas, ...New England Journal of Medicine 373 (19), 1803-1813, 201551822015
2-) Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinomaRJ Motzer, NM Tannir, DF McDermott, OA Frontera, B Melichar, ...New England Journal of Medicine, 201830702018
3-) Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinomaBI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...New England Journal of Medicine 380 (12), 1116-1127, 201920432019
4-) Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapyR Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ...Science 362 (6411), eaar3593, 201820132018
5-) Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trialP Sharma, M Retz, A Siefker-Radtke, A Baron, A Necchi, J Bedke, ...The lancet oncology 18 (3), 312-322, 201718282017